Latest raise
$23M
Date raised
November 5, 2026
Round
—
InvestorsViking Global Investors
About Jason Bhardwaj
a biotechnology company developing a corrective topical protein therapy for dystrophic epidermolysis bullosa (DEB)
- Who is Jason Bhardwaj?
- Jason Bhardwaj is listed as Co-founder and Chief Executive Officer of Nova Anchora, a biotechnology company.
- How much did Nova Anchora raise?
- Nova Anchora raised $23M on November 5, 2026 (1 days ago). Backed by Viking Global Investors.
Get newly funded founders every week
A free weekly list of startups that just raised.